"Antibiotic Dysbiosis in Preterm Infants"

PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

January 16, 2017

Primary Completion Date

September 11, 2019

Study Completion Date

September 11, 2019

Conditions
Enterocolitis, NecrotizingBacteremiaBronchopulmonary DysplasiaIntraventricular HemorrhagePeriventricular LeukomalaciaChronic Lung DiseaseIleal Perforation
Interventions
DRUG

Antibiotic

Babies that are assigned to antibiotics receive therapy based on the clinical team's discretion.

OTHER

Gastric fluid

Microbiome evaluated using gastric aspirate.

OTHER

Breast milk

Microbiome will be evaluated using mother's breast milk.

OTHER

Stool samples

Microbiome will be evaluated using infant's stool.

DRUG

Antibiotics

Babies that are randomized to antibiotics receive therapy based on the clinical team's discretion.

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

Society for Pediatric Dermatology

OTHER

lead

University of Florida

OTHER

NCT02784821 - "Antibiotic Dysbiosis in Preterm Infants" | Biotech Hunter | Biotech Hunter